ImmuCell Corp. reported a double-digit sales increase in 2020 and says it has made its last major submission to the U.S. Food and Drug Administration for a new product under development.
The Portland-based animal health products maker, which produces immunity-boosting treatments for dairy and beef cattle, reported 2020 sales of $15.3 million on Monday, up 12 percent from $13.7 million the previous year. The company suffered a net loss of $1 million, or 14 cents per share, in 2020, an improvement over its net loss of $1.3 million, or 19 cents per share, in 2019. Read more
